:FAERS

Yongjin Xie1, Jintuo Zhou2, Yingling Xie3

  • 1Department of Obstetrics and Gynecology, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Maternity and Child Health Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, China.

概括

这项研究使用FDA数据确定了32种与分娩后出血 (PPH) 相关的药物,包括催产素,丁诺普罗斯和米索普罗斯托. 调查结果强调需要监测药物诱导的PPH风险,即使是长期的.